The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pharmacogenetic determinants of gefitinib trough concentration in patients with non-small cell lung cancer.
Shuang Xin
No relevant relationships to disclose
Yuxiang Ma
No relevant relationships to disclose
Xueding Wang
No relevant relationships to disclose
Yan Huang
No relevant relationships to disclose
Jiali Li
No relevant relationships to disclose
YuanYuan Zhao
No relevant relationships to disclose
Lingyan Chen
No relevant relationships to disclose
Rong Hu
No relevant relationships to disclose
Min Huang
No relevant relationships to disclose
Li Zhang
No relevant relationships to disclose